Laborie to acquire JADA System from Organon for up to $465M

Laborie Medical Technologies agreed to acquire the JADA System, an FDA-cleared device for postpartum hemorrhage control, from Organon. The transaction is valued up to $465 million, with $440 million at closing and a $25 million milestone payment, expected to close in Q1 2026.

“Laborie announced it has entered into an agreement with Organon... to acquire the JADA System.”prnewswire.com

• 1 source
• prnewswire.comLaborie Announces Agreement to Acquire the JADA® System from OrganonLaborie Medical TechnologiesNov 7, 2025

Summarized from public sources; check the original articles before acting on it.